Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer

NCT01097018 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT01097018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01097018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Lead sponsor
AEterna Zentaris
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2012
Enrollment
468 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer